glp-1 drugs covered by medicaid GLP-1s prescriptions for weight loss are skyrocketing in North Carolina Medicare cuts cost of popular

September 3, 2024

The hidden risk of eating too little In older adults, appetite is often already reduced

Medicare Part D statutorily excludes weight-loss drugs from coverage, whereas only a minority of state Medicaid programs cover obesity medications

Close monitoring over time Regular followup visits to track weight, body composition, labs, blood pressure, and side effects

(Table 2)

But until now, there hasnt been any data from large epidemiologic studies. Results showed use of GLP-1 agonists compared with bupropion-naltrexone correlated with a 9.09 (95% CI, 1.25-66), 4.22 (95% CI, 1.02-17.4) and 3.67 (95% CI, 1.15-11.9) times higher risk for pancreatitis, bowel obstruction and gastroparesis, respectively